A. P. Freitas-do-rosario, IL-27 promotes IL-10 production by effector Th1 CD4 + T cells: a critical mechanism for protection from severe immunopathology during malaria infection, J. Immunol, vol.188, pp.1178-1190, 2012.

K. E. Kester, randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection, J. Infect. Dis, vol.200, pp.337-346, 2009.

H. Tinto, Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial, Lancet, vol.386, pp.31-45, 2015.

M. T. White, The relationship between RTS,s vaccine-induced antibodies, CD4(+) T cell responses and protection against Plasmodium falciparum infection, PLoS One, vol.8, p.61395, 2013.

J. P. Vanderberg and U. Frevert, Intravital microscopy demonstrating antibody-mediated immobilisation of Plasmodium berghei sporozoites injected into skin by mosquitoes, Int. J. Parasitol, vol.34, pp.991-996, 2004.

A. J. Lysenko, Population studies of Plasmodium vivax. 1. The theory of polymorphism of sporozoites and epidemiological phenomena of tertian malaria, Bull. World Health Organ, vol.55, pp.541-549, 1977.

C. Luxemburger, Treatment of vivax malaria on the western border of Thailand, Trans. Roy. Soc. Trop. Med. Hyg, vol.93, pp.433-438, 1999.

L. J. Robinson, Strategies for understanding and reducing the Plasmodium vivax and Plasmodium ovale hypnozoite reservoir in Papua New Guinean children: a randomised placebo-controlled trial and mathematical model, PLoS Med, vol.12, p.1001891, 2015.

M. T. White, Modelling the contribution of the hypnozoite reservoir to Plasmodium vivax transmission, vol.3, 2014.

C. Koepfli, Blood-stage parasitaemia and age determine Plasmodium falciparum and P. vivax gametocytaemia in Papua New Guinea, PLoS One, vol.10, p.126747, 2015.

S. A. Mikolajczak, Plasmodium vivax liver stage development and hypnozoite persistence in human liverchimeric mice, Cell Host Microbe, vol.17, pp.526-535, 2015.

W. E. Collins, A retrospective examination of reinfection of humans with Plasmodium vivax, Am. J. Trop. Med. Hyg, vol.70, pp.642-644, 2004.

I. Mueller, Development of vaccines for Plasmodium vivax malaria, Vaccine, vol.33, pp.7489-7495, 2015.